Trypsin Market Introduction and Overview
According to SPER Market Research, the Global Trypsin Market is estimated to reach USD 167.31 billion by 2034 with a CAGR of 5.69%.
The report includes an in-depth analysis of the Global Trypsin Market, including market size and trends, product mix, Applications, and supplier analysis. Trypsin is a crucial enzyme for protein digestion, and its increasing use across industries such as pharmaceuticals, food science research, detergents, and leather processing is expected to drive market growth. The growing focus on drug discovery and development is also contributing to this expansion. However, there are factors that may limit the growth of the global trypsin market, including its tendency for autolysis and incomplete digestion. As trypsin is a protein, it can undergo autolysis, a process where it breaks down its own cells through enzymatic activity, which could impede market progress. Additionally, when using trypsin, there is no guarantee that all proteins will be fully digested.
By Source: The bovine segment held the largest market share of 59.90% in 2024, driven by its specific cleavage activity, affordability, and wide availability. It is extensively used in vaccine production and cell culture applications. Leading companies like Merck Millipore and Thermo Fisher offer bovine trypsin for various uses. The porcine segment is expected to grow at a significant rate, with porcine trypsin used in vaccine production, though its use is now regulated and minimized.
By Application: Due to the increasing use of trypsin in high-throughput screening to investigate protein interactions and aid in drug development, the biotechnology and pharmaceutical industries dominate the market. Trypsin facilitates the development of new treatments by helping to understand the links between protein structure and function. Businesses like Novea Technologies and Thermo Scientific make investments in creating premium enzymes for a range of uses, such as nutraceuticals and diagnostics. Additionally, the use of trypsin in skincare products for skin renewal and exfoliating is driving growth in the personal care and cosmetics industry.
By End Use: In 2024, the market's largest share was held by the industrial usage category. This expansion is fueled by the increasing use of trypsin in sectors like food and medicine, detergents, and leather processing. Though its application is restricted because of safety and environmental issues, trypsin aids in the removal of protein-based stains such as blood and egg in detergents. Trypsin is used to enhance the emulsification, foaming, solubility, and gelling of food proteins in the food and pharmaceutical industries.
By Regional Insights: North America led the global trypsin market in 2024, capturing a significant share. This dominance is attributed to the presence of major market players like Bio-Rad Laboratories, Creative Enzymes, Hawkins, Agilent Technologies, Promega Corporation, and Thermo Fisher Scientific. Collaborations and partnerships among these companies have further driven regional market growth. Moreover, the rising prevalence of conditions such as pancreatitis, cystic fibrosis, and cancer is expected to boost demand for trypsin in diagnostic applications.
Market Competitive Landscape:
The market is highly consolidated. Some of the market key players are Agilent Technologies, BBI Solutions, BIOZYM, Bovogen Biologicals, Linzyme Biosciences, Merck Millipore, Neova Technologies, Novozymes, Promega Corporation, PromoCell GmbH, Sartorius AG, and Thermo Fisher Scientific, along with others.
Recent Developments:
- In January 2024, Trypsin-Chymotrypsin, a potent blend of proteolytic enzymes that is expected to propel major breakthroughs in a number of industries, was unveiled by Creative Enzymes, a world leader in enzyme-related goods and services. In the scientific community, this launch marks a significant turning point with the goal of improving operational efficiency.
- Sun Pharma India completed the purchase of Aksigen's Disperzyme and Phlogam brands in January 2023. These medications, which are especially made for patients having minor surgery to help control the inflammatory response, are the first enzyme-bioflavonoid combos to finish scientific investigations and obtain DCGI approval in India.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Source, By Application, By End Use. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Agilent Technologies, BBI Solutions, BIOZYM, Bovogen Biologicals, Linzyme Biosciences, Merck Millipore, Neova Technologies, Novozymes, Promega Corporation, PromoCell GmbH, Sartorius AG, and Thermo Fisher Scientific, along with and others. |
Key Topics Covered in the Report:
- Global Trypsin Market Size (FY’2021-FY’2034)
- Overview of Global Trypsin Market
- Segmentation of Global Trypsin Market By Source (Bovine, Porcine, Others)
- Segmentation of Global Trypsin Market By Application (Biotechnology and Pharmaceutical Industry, Food Industry, Cosmetics and Personal Care, Waste Treatment, Others)
- Segmentation of Global Trypsin Market By End Use (Research, Diagnostic, Industrial use)
- Statistical Snap of Global Trypsin Market
- Expansion Analysis of Global Trypsin Market
- Problems and Obstacles in Global Trypsin Market
- Competitive Landscape in the Global Trypsin Market
- Details on Current Investment in Global Trypsin Market
- Competitive Analysis of Global Trypsin Market
- Prominent Players in the Global Trypsin Market
- SWOT Analysis of Global Trypsin Market
- Global Trypsin Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Trypsin Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Trypsin Market
7. Global Trypsin Market, By Source, (USD Million) 2021-2034
7.1. Bovine
7.2. Porcine
7.3. Others
8. Global Trypsin Market, By Application, (USD Million) 2021-2034
8.1. Biotechnology and Pharmaceutical Industry
8.2. Food Industry
8.3. Cosmetics and Personal Care
8.4. Waste Treatment
8.5. Others
9. Global Trypsin Market, By End Use, (USD Million) 2021-2034
9.1. Research
9.2. Diagnostic
9.3. Industrial use
10. Global Trypsin Market, (USD Million) 2021-2034
10.1. Global Trypsin Market Size and Market Share
11. Global Trypsin Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Agilent Technologies
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. BBI Solutions
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. BIOZYM
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Bovogen Biologicals
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Linzyme Biosciences
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Merck Millipore
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Neova Technologies
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Novozymes
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Promega Corporation
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. PromoCell GmbH
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Sartorius AG
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Thermo Fisher Scientific
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links